ICD-10 Specific code F33.1: Recurrent depressive disorder, current episode moderate
Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
Translations
| Language | Translation |
|---|---|
English
|
Recurrent depressive disorder, current episode moderate |
French
|
Trouble dépressif récurrent, épisode actuel moyen |
Hierarchical position
| Level | Code | Title | |
|---|---|---|---|
| 1 | V | Mental and behavioural disorders | |
| 2 | F30-F39 | Mood [affective] disorders | |
| 3 | F33 | Recurrent depressive disorder | |
| 4 | F33.1 | Recurrent depressive disorder, current episode moderate |
Indicated medicines
| Active Ingredient |
|---|
|
Amitriptyline is a tricyclic antidepressant and an analgesic. It prevents the re-uptake, and hence the inactivation of noradrenaline and serotonin at nerve terminals. Reuptake prevention of these monoamine neurotransmitters potentiate their action in the brain. This appears to be associated with the antidepressant activity. |
|
Citalopram is the most Selective Serotonin Reuptake Inhibitor (SSRI) yet described, with no, or minimal, effect on noradrenaline (NA), dopamine (DA) and gamma aminobutyric acid (GABA) uptake. |
|
Quetiapine is an atypical antipsychotic agent. Quetiapine and the active human plasma metabolite, norquetiapine interact with a broad range of neurotransmitter receptors. |
|
Trazodone is a potent antidepressant. It also has anxiety reducing activity. Trazodone is a triazolopyridine derivative chemically unrelated to known tricyclic, tetracyclic and other antidepressant agents. It has negligible effect on noradrenaline re-uptake mechanisms. |